Follow the 동화약품 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 동화약품 has published 2 insider filings. Market capitalisation: €128.3bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: 동화약품. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
동화약품 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en la investigación, desarrollo y producción de medicamentos y productos farmacéuticos.